May 21, 2020
Healthcare workers to participate in chloroquine study
Editor's Note
An international study will include more than 30,000 front-line healthcare workers to assess whether chloroquine can prevent COVID-19 or decrease its severity.
Washington University School of Medicine in St Louis is the clinical coordinating center for the study.
Healthcare workers will be divided randomly into four groups. Three groups will receive chloroquine at various doses, and the fourth group will receive a placebo.
The study will last 5 months.
Free Daily News
- Hospital safety grades show progress in reducing medical errors, infections
- Analysis: Overuse of back surgeries costs Medicare $2 billion, risks patient safety
- AI-powered surgical robot learns by watching
- AHA's Congressional "wish list" calls for financial relief, patient access, workforce protections
- Out-of-hospital cardiac arrest survival rates lag pre-pandemic levels, racial disparities persist
- Honoring the OR Manager Award winners this Perioperative Nurses Week
- Study: Demand for anesthesiologists rises sharply, driven by job market, regional variations
- Joint Commission Sentinel Event Alert details environmental disaster preparation
- ACS recognizes 77 hospitals for excellence in surgical outcomes
- Color-changing gel could enhance cataract surgery safety, efficiency
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement